BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Medilink Midlands - ECPv6.15.20//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://staging.medilinkmidlands.com
X-WR-CALDESC:Events for Medilink Midlands
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Europe/London
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20190331T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20191027T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20200329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20201025T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20210328T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20211031T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20200904T130000
DTEND;TZID=Europe/London:20200904T143000
DTSTAMP:20260423T051031
CREATED:20200824T082519Z
LAST-MODIFIED:20200824T082519Z
UID:18336-1599224400-1599229800@staging.medilinkmidlands.com
SUMMARY:Lifescience Industry News Industry Spotlight
DESCRIPTION:Examining the UK response to Covid-19\nAhead of the Lifescience Industry Magazine being published\, Lifescience Industry Magazine is hosting a webinar\, on 4th September at 1 pm\, spotlighting some of the great stories of how the UK has responded to the pandemic. \nShowcasing how the life science and health tech sector worked\, collaborated and persevered during these challenging times. \nEach of Lifescience Industry’s partners will be introducing companies from across the UK\, further program details to follow shortly. \nConfirmed speakers include: \n\nJames Hindley\, Executive Director of Indoor Biotech\nDr Roberto Liddi\, Senior Vice President Quality Regulatory and IG Compliance at Sensyne Health\nNeil Cambell\, Chief Executive Officer for Inspiration Healthcare Group\nSven Bunn\, Life Sciences Programme Director at Barts Health NHS Trust\n\nLifescience Industry magazine is a collaboration between regional\, national and international life science partners. It includes the latest news and developments from the life science industry\, with editorial covering the complete health technology spectrum\, as well as funding\, trade and collaboration opportunities. \nTo register for this event\, click here
URL:https://staging.medilinkmidlands.com/event/lifescience-industry-news-industry-spotlight/
CATEGORIES:Medilink Partner Event
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20200910T100000
DTEND;TZID=Europe/London:20200910T110000
DTSTAMP:20260423T051031
CREATED:20200810T113723Z
LAST-MODIFIED:20200810T113723Z
UID:18316-1599732000-1599735600@staging.medilinkmidlands.com
SUMMARY:R&D Tax Credits and Accounting for Development Expenditure
DESCRIPTION:Have you recently applied for UK Government funding grant or recently been awarded one?  Then this is the webinar for you! \nSEHTA and Edwards Chartered Accountants are pleased to launch their first webinar on R&D tax credits and accounting for companies who are engaged in developing new science or technology and who have recently received or in the process of applying for a UK government grant.\nDate: Thursday 10th September 2020 \nTime: 10:00 – 11:00 (UK Times) \nCosts: SEHTA Members: £65 + VAT per delegate / Non-Members:  £75 + VAT per delegate\n​Not a member of SEHTA? – it’s free to join\nThese webinars will be run via WEBEX – details on application \nOverview of the webinar \nR&D tax credits: \n\nDetails of the two schemes which are available (Small & RDEC)\nExample calculations to demonstrate the tax savings / refunds available to companies\nDetails of the procedure of making an R&D claim\nDetails of what costs qualify for R&D tax credits and eligibility criteria\nDetails of proposed future changes to the scheme and COVID-19 related tips\n\nAccounting for development expenditure: \n\nDetails of the two options available to companies\nPros and cons of both options and why a company may want to consider changing their accounting policy for development expenditure\nDetails of the procedure which can be implemented if a company decides to change its accounting policy for development expenditure including eligibility criteria\n\nTarget audience:  Any company which is engaged in developing new science or technology\, and any company which is currently in the process of applying for or has recently received a UK government grant. \nPlaces are limited so register today to guarantee your place \nClick here to book
URL:https://staging.medilinkmidlands.com/event/rd-tax-credits-and-accounting-for-development-expenditure/
CATEGORIES:Medilink Partner Event
ORGANIZER;CN="SEHTA":MAILTO:info@sehta.co.uk
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20200915T140000
DTEND;TZID=Europe/London:20200915T150000
DTSTAMP:20260423T051031
CREATED:20200810T091214Z
LAST-MODIFIED:20200810T091214Z
UID:18313-1600178400-1600182000@staging.medilinkmidlands.com
SUMMARY:The Killer Issue: How to mitigate risk when designing in-vivo devices
DESCRIPTION:SEHTA & eg technology  \nSeries of In-vivo devices\, Microfluidics and Diagnostics Webinars \nSeptember 2020 \nSEHTA and eg technology are delighted to announce a series of webinars on the topics of In-vivo devices\, Microfluidics and Diagnostics to enable you to continue to update your skillset and move your medical technologies and companies forward. \nEach session will run for 1 hour:  14:00 – 15:00 (UK time) \nThese webinars will be run via WEBEX – details on application \nRisk goes hand in hand with medical device design and development – intervening in the human body will always have the potential to go wrong. But what happens when device limitations could result in serious injury or even death? Join egt director\, Danny Godfrey as he looks specifically at the design and development of in-vivo devices and how risks are identified\, managed\, and mitigated to minimize the risk of potentially catastrophic outcomes. \nStarting with a brief overview of the medical device development process\, this webinar will address the importance of examining the full use cycle of your device and identifying risks early on in your project – including less obvious and sometimes unseen obstacles – whilst ensuring full traceability throughout. \nTopics to be covered include: \n\nThe key things to consider from the outset of any development programme\nHow to identify the full spectrum of potential risks \nWhen in your programme this should happen\nThe importance of device classification and mapping risks against standards\nHow to mitigate risks to allow you to get on with your design\n\nTarget audience for these webinars are: Medical Technology Entrepreneurs\, Medical Device Software Developers\, Technology Transfer Officers\, Medical Technology University Researchers\, IVD Developers\, Business Owners\, Executives\, Product Owners\, Regulatory Specialists within a company that need to understand the overall regulatory requirements for their medical devices to enable them to place a device on the market and to maintain access. All company sizes will find it useful. \nCosts to attend: \nEarly bird rate – book by 31st August 2020 \n£55 + VAT pp per webinar for members / £65 + VAT non-members \nAfter 31st August 2020 \n£65 +VAT pp per webinar for members / £75 + VAT non members \nNot a member of SEHTA – it’s free to join – https://www.sehta.co.uk/Post/sehta-membership \nFor more information and to book\, click here
URL:https://staging.medilinkmidlands.com/event/the-killer-issue-how-to-mitigate-risk-when-designing-in-vivo-devices/
CATEGORIES:Medilink Partner Event
ORGANIZER;CN="SEHTA":MAILTO:info@sehta.co.uk
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20200916T140000
DTEND;TZID=Europe/London:20200916T150000
DTSTAMP:20260423T051031
CREATED:20200810T091604Z
LAST-MODIFIED:20200810T091604Z
UID:18314-1600264800-1600268400@staging.medilinkmidlands.com
SUMMARY:Microfluidics; small technology\, big pitfalls
DESCRIPTION:Series of In-vivo devices\, Microfluidics and Diagnostics Webinars \nSeptember 2020 \nSEHTA and eg technology are delighted to announce a series of webinars on the topics of In-vivo devices\, Microfluidics and Diagnostics to enable you to continue to update your skillset and move your medical technologies and companies forward. \nEach session will run for 1 hour:  14:00 – 15:00 (UK time) \nThese webinars will be run via WEBEX – details on application \nIt is estimated that the Global Microfluidics Market will have a value of over USD 53 billion by the end of 2027\, but how much do you really know about Microfluidics and how it fits in to a design programme? \nThis webinar will look at the various development challenges when working with Microfluidics. Starting with an overview of applications and fabrication technologies\, we will then discuss the relationship between single use consumables and multi-use products with examples\, the different fluid handling technologies and then move on to the main developmental obstacle; identifying\, assessing and overcoming the many pitfalls associated with Microfluidics. \nThis webinar will cover: \n\nAn overview of Microfluidics and how it is incorporated into development programmes\nUnderstanding the different technologies available and identifying the most suitable option for your programme\nThe importance of identifying and assessing risks early in your programme and overcoming these development challenges\n\nTarget audience for these webinars are: Medical Technology Entrepreneurs\, Medical Device Software Developers\, Technology Transfer Officers\, Medical Technology University Researchers\, IVD Developers\, Business Owners\, Executives\, Product Owners\, Regulatory Specialists within a company that need to understand the overall regulatory requirements for their medical devices to enable them to place a device on the market and to maintain access. All company sizes will find it useful. \nCosts to attend: \nEarly bird rate – book by 31st August 2020 \n£55 + VAT pp per webinar for members / £65 + VAT non-members \nAfter 31st August 2020 \n£65 +VAT pp per webinar for members / £75 + VAT non members \nNot a member of SEHTA – it’s free to join – https://www.sehta.co.uk/Post/sehta-membership \nFor more details and to book\, click here
URL:https://staging.medilinkmidlands.com/event/microfluidics-small-technology-big-pitfalls/
CATEGORIES:Medilink Partner Event
ORGANIZER;CN="SEHTA":MAILTO:info@sehta.co.uk
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20200917T140000
DTEND;TZID=Europe/London:20200917T150000
DTSTAMP:20260423T051031
CREATED:20200810T091846Z
LAST-MODIFIED:20200810T091846Z
UID:18315-1600351200-1600354800@staging.medilinkmidlands.com
SUMMARY:Diagnosing the risk in diagnostics development; man versus machine
DESCRIPTION:Series of In-vivo devices\, Microfluidics and Diagnostics Webinars \nSeptember 2020 \nSEHTA and eg technology are delighted to announce a series of webinars on the topics of In-vivo devices\, Microfluidics and Diagnostics to enable you to continue to update your skillset and move your medical technologies and companies forward. \nEach session will run for 1 hour:  14:00 – 15:00 (UK time) \nThese webinars will be run via WEBEX – details on application \nThe design and development of Diagnostic devices within the medical industry is a complex process\, fraught with usability uncertainties. Many clinicians are reluctant to make a diagnosis without the confirmation of a device\, but devices cannot always be used in isolation as they do not have the full picture and patient knowledge of the clinician. This dichotomy makes the development of such devices often difficult. So\, how do we develop a diagnostics device which satisfies the product\, patient\, and clinician requirement specifications? Furthermore\, how can we develop a diagnostics strategy that addresses the codependence of diagnostic devices and their user? \nThis webinar will focus on what it takes to produce a diagnostics device which not only meets requirements but lives up to its marketing. Looking at the user and usability requirements\, how your device should be classified and the importance of creating a defined strategy\, we will discuss the human factors involved with diagnostics design and how total reliance on the device is not always the best option.  \nTopics to be covered include: \n\nThe key considerations in a diagnostics device development programme\nThe importance of identifying your product strategy early in your programme\nHow to keep usability and the end-user in mind throughout\nNavigating the regulatory process\nClosing the design loop – ensuring your end product does what you say it does!\n\nTarget audience for these webinars are: Medical Technology Entrepreneurs\, Medical Device Software Developers\, Technology Transfer Officers\, Medical Technology University Researchers\, IVD Developers\, Business Owners\, Executives\, Product Owners\, Regulatory Specialists within a company that need to understand the overall regulatory requirements for their medical devices to enable them to place a device on the market and to maintain access. All company sizes will find it useful. \nCosts to attend: \nEarly bird rate – book by 31st August 2020 \n£55 + VAT pp per webinar for members / £65 + VAT non-members \nAfter 31st August 2020 \n£65 +VAT pp per webinar for members / £75 + VAT non members \nNot a member of SEHTA – it’s free to join – https://www.sehta.co.uk/Post/sehta-membership \nFor more details\, and to book your place\, click here
URL:https://staging.medilinkmidlands.com/event/diagnosing-the-risk-in-diagnostics-development-man-versus-machine/
CATEGORIES:Medilink Partner Event
ORGANIZER;CN="SEHTA":MAILTO:info@sehta.co.uk
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20200928
DTEND;VALUE=DATE:20200929
DTSTAMP:20260423T051031
CREATED:20190923T123050Z
LAST-MODIFIED:20190923T123050Z
UID:18015-1601251200-1601337599@staging.medilinkmidlands.com
SUMMARY:SEHTA's 1st International MedTech Expo & Conference
DESCRIPTION:The SME focused healthcare event for driving collaborations between Business\, Care & Clinicians & Academics \nSEHTA’s 1st International MedTech Expo & Conference \nDevices\, Diagnostics\, Digital\nAt one EVENT & in one DAY \nOver the last 15 years\, South East Health Technologies Alliance (SEHTA) has developed an excellent reputation for support of its 1\,300 members\, especially SMEs\, through its one to one mentoring\, fund-finding\, consultancy and events programme. \nIn 2020\, for the first time\, SEHTA is organising a major new international event in London designed to take the programme of support to another level. \nWe cordially invite you to join us on Thursday 26th March 2020 for SEHTA’s first International MedTech Expo & Conference taking place at the Hilton London Tower Bridge. This event is aimed at SME’s\, Corporates\, Academics & NHS Healthcare Providers. \nThe conference and expo aims to help delegates: \nUnderstand: Make sense of the complexities of healthcare support and challenges of accessing the NHS \nFind: Funding opportunities (public sector\, private\, NHS) \nNavigate: Regulatory\, legal and IP issues \nIdentify: Current clinical challenges in the NHS \nAnd perhaps most of all…. Make new contacts leading to collaborative partnerships at the event and through our bespoke 1:1 partnering website\n(available from January 2020 to book your meetings) \nFor further information\, please click here to email SEHTA.
URL:https://staging.medilinkmidlands.com/event/sehtas-1st-international-medtech-expo-conference/
LOCATION:Hilton London Tower Bridge\, 5 More London Riverside\, London\, SE1 2BY
CATEGORIES:Medilink Partner Event
ORGANIZER;CN="SEHTA":MAILTO:info@sehta.co.uk
END:VEVENT
END:VCALENDAR